As of Apr 20
| -0.016 / -0.48%|
The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +79.96% increase from the last price of 3.33.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.